Neugut, Alfred I.
Hillyer, Grace Clarke
Kushi, Lawrence H.
Lamerato, Lois
Buono, Donna L.
Nathanson, S. David
Bovbjerg, Dana H.
Mandelblatt, Jeanne S.
Tsai, Wei-Yann
Jacobson, Judith S.
Hershman, Dawn L.
Funding for this research was provided by:
Congressionally Directed Medical Research Programs (BC043120)
National Cancer Institute (R01 CA105274, K05 CA96940)
U.S. Department of Defense (DAMD-17-01-1-0334)
Breast Cancer Research Foundation
Article History
Received: 3 May 2016
Accepted: 3 June 2016
First Online: 10 June 2016
Compliance with ethical standards
:
: Dr. Neugut has served as a consultant to Pfizer, Teva, Otsuka, and United Biosource Corporation. He is on the medical advisory board of EHE, Intl. No other authors report any potential conflicts of interest. All of the authors are responsible for the data analysis and interpretation.